UPDATE: GlaxoSmithKline CEO Bonus Hit By China Probe, But Total Pay Still Jumps
LONDON (Alliance News) - GlaxoSmithKline PLC Chief Executive Andrew Witty took a hit to his annual bonus for 2013 as a result of ongoing investigations in China, although his total pay for the year still rose 63% as the company got six products approved and five additional regulatory filings comp Read More